Evonik acquires the polyurethane additives business of BYK-Chemie GmbH, a division of ALTANA AG
Evonik is a market leader in polyurethane additives, its key products being foam stabilizers. Evonik has excellent market access worldwide, a very good reputation in the industry, a wealth of experience in the formulation of polyurethane foam systems and foresees substantial growth prospects for the polyurethane additives segment due to its very high application and product development expertise. The transaction allows the Polyurethane Additives Business Line of Evonik to enhance its existing business in some market segments and to strengthen its overall market position in the long term.
The total market for polyurethane additives is growing continuously. Asia, especially China, is a regional growth market, and Evonik already has a strong market presence with its PU additives in this region. In addition to polyurethane foam stabilizers, the Evonik portfolio includes metal and amine catalysts, release agents, colorants, antioxidants, antistatic agents and other performance additives used in the manufacturing of polyurethane foams and to provide certain physical properties to the final foam products.
Disclaimer In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.
Evonik Industries AG
Evonik Industries is the creative industrial group from Germany. In our core business of specialty chemicals, we are a global leader. In addition, Evonik is an expert in power generation from hard coal and renewable energies, and one of the largest private residential real estate companies in Germany. Our company's performance is shaped by creativity, specialization, continuous selfrenewal, and reliability.
Evonik is active in over 100 countries around the world. In its fiscal year 2009 about 39,000 employees generated sales of about €13.1 billion and an operating profit (EBITDA) of about €2.0 billion.